We are international
Donate
• about myeloma TEXT SIZE   
publications    back

Myeloma Minute
December 12, 2013
12.12.13

December 12, 2013

Share the Minute

Facebook

Tweet!

Clinical Trials

Donate to the IMF

 



Upcoming Events

Thursday, January 16, 2014
Best of ASH 2013:
What Patients Need to Know
Teleconference
4 pm PT / 7 pm ET
Register Now!


IN CASE YOU MISSED IT...
Watch IMF Events Recorded
Live from New Orleans


IMWG Conference Series

Intl Journalists' Workshop

IMF Symposium



Visit IMF's Sparkly
New Holiday Gift Store

Research at ASH 2013 Points the Way Forward for Myeloma Patients

A panel of myeloma experts zeroed in on research presented at ASH 2013 pointing the way forward for patients at Monday night's IMWG Conference Series: Making Sense of Treatment. Brian G.M. Durie, MD, Chairman and Co-founder of the IMF, moderated the webcast, which focused on the most important myeloma topics at ASH 2013: frontline treatment, maintenance, minimal residual disease and new drugs. READ DR. DURIE'S ASH 2013 RECAP

x

 

IMF Announces Partnership with Onyx Pharmaceuticals to Support Black Swan Research Initiative®

The IMF made news of its own at ASH, announcing the start of a multi-year collaboration with Onyx Pharmaceuticals, Inc., an Amgen subsidiary, in support of the Black Swan Research Initiative® (BSRI®). "As new treatment options are improving outcomes and quality of life for patients, the BSRI team is committed to now move forward to the next stage in advancing science, with the ultimate goal of curing patients," said Susie Novis, President and Co-founder of the IMF. "We are grateful for Onyx's belief in BSRI and their commitment to myeloma patients." READ THE FULL ANNOUNCMENT HERE

x

 

IMF's Video Team Interviews Myeloma Experts on Groundbreaking Research at ASH 2013

IMF's video team checked in with dozens of the world's top myeloma experts in New Orleans to learn more about cutting-edge research at ASH 2013. For example, molecular testing studies are showing the need for more and better combination therapies to target myeloma clones, according to Dr. Wee-Joo Chng, of the National University Health System in Singapore. What else? WATCH IMF VIDEO INTERVIEWS FROM ASH 2013

x

 

IMF's Social Media Team Members Lead the List of Twitter "Influencers" @ #ASH13

Myeloma support group leaders ruled the social media scene at ASH by sharing the latest clinical updates in research, therapies and practice strategies—through the eyes of a patient— on Twitter, Facebook, blogs and videos. The social media analytics company Symplur reports that IMF's social media team members were among the Top Ten by number of mentions and the Top Ten by numbers of Tweets in the myeloma category. READ PERSONAL PERSPECTIVES ON ASH 2013

 



 

 

x

Join Our Mailing List
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles